Technology | March 27, 2012

FDA Clears GE Healthcare’s New Class of Angiography Systems

Class offers fixed system image quality and features with versatility of a mobile C-arm

The GE Healthcare Discovery IGS 730 angiography imaging system.

March 26, 2012 – GE Healthcare unveiled two recently U.S. Food and Drug Administration (FDA)-cleared angiography systems offering mobility and advanced imaging for interventional cardiology at the American College of Cardiology's (ACC) 61st Annual Scientific Session in Chicago this week. 

Specifically, GE highlighted its recently FDA-cleared Discovery IGS 730 system, the first interventional X-ray system designed to capture the advantages of both floor- and ceiling-mounted systems, and the mobility of a mobile C-arm. Initially introduced last fall during RSNA 2011, the Discovery system was designed to address the trade-off departments have historically needed to make between ceiling- and floor-mounted systems, eliminating the need to compromise on patient access and image quality. This laser-guided, motorized mobile gantry allows complete access to the patient and unlimited parking capability, while creating sterility for a flexible operating room (OR) environment. The unique gantry comes with a new wide bore design, which allows for steep angles, ease in 3-D acquisition, especially for large patients. 

GE will also introduce the FDA-approved Innova IGS 520/530 with the OR option to expand the use of its Innova imaging system in the hybrid OR setting. With specifically designed table and accessories, the Innova IGS 520/530 OR enables both transcatheter and open surgical procedures in one room.

GE also highlighted its Innova HeartVision solution to help support planning and guidance of structural heart procedures, especially trans-aortic valve replacement (TAVR) procedures. The HeartVision function fuses real time 2-D X-ray images and 3-D models, such as the 3-D cardiac model, from multiple modalities. It can be synchronized with electrocardiogram (ECG) gating and can help compensate for patient heart and respiratory motion throughout the procedure for quality treatment. Innova HeartVision can reduce procedure time and dose, and increase physician confidence by providing the visual tools to make challenging interventions more accessible.

“Interventional cardiology procedures are becoming increasingly complex, and now may be performed in a variety of settings in the hospital, including the operating room. GE Healthcare is revolutionizing cardiac imaging with solutions that adapt to a wider array of environments,” said Reaz Rasul, general manager, interventional cardiology, GE Healthcare - detection and guidance solutions. “With the development of Discovery IGS 730 and Innova IGS 520/530 OR, we are arming physicians with solutions that combine cutting-edge imaging with greater versatility to meet more clinical needs.”

To see a video of the system in operation when it was first unveiled at RSNA 2011, click here.

For more information: www.gehealthcare.com

Related Content

Prosthetic Valve Mismatches Common in TAVR Procedures
News | Heart Valve Technology | October 03, 2018
A high number of patients in a study who underwent transcatheter aortic valve replacement (TAVR) experienced severe and...
Local Anesthesia Safe and Effective for Intermediate- and High-Risk TAVR Patients
News | Heart Valve Technology | September 28, 2018
The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (...
MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation
News | Heart Valve Technology | September 26, 2018
Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic despite maximally...
Ancora Heart Announces Positive Interim Analysis of AccuCinch Ventricular Repair System for Heart Failure
News | Heart Valve Technology | September 24, 2018
Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early feasibility study...
Medtronic Announces TAVR Study of Aortic Stenosis Patients With Bicuspid Valves
News | Heart Valve Technology | September 19, 2018
The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) to initiate a new...
4C Medical's AltaValve First-in-Human Experience to be Presented at TCT 2018
News | Heart Valve Technology | September 17, 2018
September 17, 2018 — 4C Medical Technologies Inc.
Gore Acquires Pipeline Medical Technologies Inc.
News | Heart Valve Technology | September 06, 2018
W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical Technologies Inc., a privately...
The Edwards Lifesciences Cardioband Tricuspid Valve Reconstruction System received the European CE mark approval in May.

The Edwards Cardioband Tricuspid Valve Reconstruction System received the European CE mark approval in May, becoming the first transcatheter tricuspid repair device to be approved in the world.

Feature | Heart Valve Technology | August 21, 2018 | Jeff Zagoudis
The tricuspid valve has been dubbed “the forgotten valve” by many practitioners in the interventional cardiology spac
Earlier Intervention for Mitral Valve Disease May Lead to Improved Outcomes
News | Heart Valve Technology | July 26, 2018
The number of patients undergoing mitral valve operations are at an all-time high, and new research suggests many...
Overlay Init